Eton Pharmaceuticals, Inc. (ETON) Stock Overview
Explore Eton Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Eton Pharmaceuticals, Inc. (ETON)
Key Financials
Key Financials
Market Cap
1.7B
P/E Ratio
135.27
EPS (TTM)
$-0.07
ROE
0.40%
ETON Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Eton Pharmaceuticals, Inc. (NASDAQ: ETON) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Eton Pharmaceuticals, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of ETON on the NASDAQ shows an RSI of 73.46, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $36.61 for the NASDAQ listing.
Key metrics behind Eton Pharmaceuticals, Inc.'s NASDAQ-traded stock include a P/E ratio of 135.27 and a market capitalization of 1.7B. Combined with our AI analysis, these give both institutional and retail investors a clear view of ETON on the NASDAQ.